Related Experiment Video

Updated: Aug 18, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

Critical periods of suicide risk in Huntington's disease

Jane S Paulsen1, Karin Ferneyhough Hoth, Carissa Nehl

  • 1Department of Psychology, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, 1-305 Medical Education Bldg., Iowa City, IA 52241-1000, USA. jane-paulsen@uiowa.edu

The American Journal of Psychiatry
|April 1, 2005
PubMed

Insights

Contrary to popular belief, a Huntington's disease diagnosis may not increase suicide risk. Suicidal ideation is highest before diagnosis and early in the disease, suggesting critical periods for intervention.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Huntington's disease is a fatal neurodegenerative disorder.
  • Suicidal ideation is a significant concern in neurodegenerative diseases.
  • Previous research has not clearly identified periods of heightened suicide risk in Huntington's disease.

Purpose of the Study:

  • To examine suicidal ideation in individuals at risk for and diagnosed with Huntington's disease.
  • To identify critical periods associated with increased suicide risk in Huntington's disease.

Main Methods:

  • Analysis of data from 4,171 individuals in the Huntington Study Group database.
  • Categorization of participants based on neurological examination (0-3) and Huntington's disease stage (1-5).
  • Assessment of suicidal ideation frequency across different stages of disease risk and diagnosis.

Main Results:

  • Suicidal ideation increased from 9.1% in at-risk individuals with normal exams to 23.5% in those with possible Huntington's disease.
  • In diagnosed patients, suicidal ideation was 16.7% in stage 1 and 21.6% in stage 2, decreasing in later stages.
  • Two critical periods for elevated suicide risk were identified: pre-diagnosis and stage 2 of Huntington's disease.

Conclusions:

  • The risk of suicidal ideation in Huntington's disease is not constant and appears highest before diagnosis and in early symptomatic stages.
  • Healthcare providers should be aware of these critical periods to implement timely interventions.
  • Further research is needed to understand the mechanisms underlying suicidal ideation in Huntington's disease.

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...